Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Antibodies | 177 | 2024 | 1303 | 13.040 |
Why?
|
Antibodies, Neutralizing | 183 | 2024 | 1943 | 10.230 |
Why?
|
HIV-1 | 206 | 2024 | 6863 | 8.130 |
Why?
|
AIDS Vaccines | 72 | 2024 | 896 | 5.610 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 65 | 2024 | 369 | 5.200 |
Why?
|
Simian immunodeficiency virus | 47 | 2024 | 809 | 4.380 |
Why?
|
HIV Envelope Protein gp120 | 65 | 2024 | 914 | 3.710 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 36 | 2024 | 541 | 3.550 |
Why?
|
Neutralization Tests | 71 | 2023 | 728 | 3.240 |
Why?
|
HIV Infections | 150 | 2024 | 17354 | 3.190 |
Why?
|
Macaca mulatta | 62 | 2024 | 2329 | 2.150 |
Why?
|
SAIDS Vaccines | 13 | 2022 | 145 | 1.950 |
Why?
|
Gene Products, env | 14 | 2020 | 250 | 1.930 |
Why?
|
Epitopes | 59 | 2024 | 2503 | 1.920 |
Why?
|
Antibodies, Monoclonal | 58 | 2024 | 9177 | 1.730 |
Why?
|
HIV Envelope Protein gp41 | 21 | 2024 | 303 | 1.540 |
Why?
|
Antibodies, Viral | 38 | 2024 | 3156 | 1.540 |
Why?
|
Immunization, Passive | 13 | 2021 | 616 | 1.450 |
Why?
|
Polysaccharides | 25 | 2023 | 1014 | 1.400 |
Why?
|
Vaccines, DNA | 16 | 2024 | 286 | 1.230 |
Why?
|
Viremia | 20 | 2023 | 707 | 1.220 |
Why?
|
Smallpox Vaccine | 7 | 2024 | 77 | 1.200 |
Why?
|
Vaccinia virus | 13 | 2024 | 331 | 1.180 |
Why?
|
Immunization, Secondary | 16 | 2024 | 367 | 1.080 |
Why?
|
Viral Vaccines | 12 | 2020 | 596 | 1.080 |
Why?
|
HIV Antigens | 15 | 2024 | 325 | 1.070 |
Why?
|
Antibodies, Bispecific | 8 | 2023 | 196 | 0.900 |
Why?
|
Viral Load | 32 | 2024 | 3332 | 0.840 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 37 | 0.810 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2020 | 357 | 0.770 |
Why?
|
CD4-Positive T-Lymphocytes | 25 | 2022 | 4369 | 0.750 |
Why?
|
Binding Sites, Antibody | 12 | 2023 | 337 | 0.750 |
Why?
|
HIV Envelope Protein gp160 | 8 | 2018 | 92 | 0.740 |
Why?
|
Antigens, Viral | 15 | 2023 | 988 | 0.740 |
Why?
|
HIV Seropositivity | 10 | 2024 | 960 | 0.720 |
Why?
|
Virus Internalization | 8 | 2020 | 497 | 0.710 |
Why?
|
Immunoglobulin Fab Fragments | 13 | 2021 | 445 | 0.710 |
Why?
|
Protein Engineering | 12 | 2022 | 549 | 0.690 |
Why?
|
B-Lymphocytes | 23 | 2024 | 4758 | 0.680 |
Why?
|
Vaccination | 21 | 2024 | 3384 | 0.670 |
Why?
|
Immunoglobulin A | 8 | 2022 | 978 | 0.670 |
Why?
|
Cross Reactions | 17 | 2021 | 817 | 0.670 |
Why?
|
Antibody Formation | 16 | 2020 | 1395 | 0.640 |
Why?
|
Immunoglobulin G | 23 | 2023 | 4544 | 0.620 |
Why?
|
Immunologic Memory | 10 | 2014 | 1359 | 0.600 |
Why?
|
Animals | 150 | 2024 | 168475 | 0.580 |
Why?
|
Anti-Retroviral Agents | 9 | 2024 | 1784 | 0.570 |
Why?
|
Antibody Specificity | 16 | 2019 | 1060 | 0.550 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2020 | 694 | 0.550 |
Why?
|
HIV | 7 | 2020 | 1582 | 0.540 |
Why?
|
T-Lymphocytes, Cytotoxic | 7 | 2009 | 1784 | 0.530 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 496 | 0.530 |
Why?
|
Antibody Affinity | 10 | 2022 | 246 | 0.510 |
Why?
|
Immunity, Cellular | 12 | 2021 | 1560 | 0.500 |
Why?
|
Influenza Vaccines | 1 | 2022 | 768 | 0.490 |
Why?
|
Immunization | 12 | 2021 | 1227 | 0.490 |
Why?
|
Models, Molecular | 24 | 2022 | 5439 | 0.480 |
Why?
|
Adenoviridae | 11 | 2018 | 1085 | 0.480 |
Why?
|
Viral Envelope Proteins | 6 | 2014 | 640 | 0.480 |
Why?
|
Genetic Vectors | 14 | 2023 | 3396 | 0.460 |
Why?
|
Adenoviruses, Human | 6 | 2014 | 255 | 0.460 |
Why?
|
Binding Sites | 23 | 2024 | 6056 | 0.460 |
Why?
|
HEK293 Cells | 25 | 2021 | 4281 | 0.460 |
Why?
|
Membrane Fusion | 4 | 2021 | 266 | 0.430 |
Why?
|
Amino Acid Sequence | 34 | 2019 | 13446 | 0.420 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2012 | 83 | 0.410 |
Why?
|
Protein Conformation | 19 | 2022 | 3968 | 0.390 |
Why?
|
Humans | 218 | 2024 | 761596 | 0.390 |
Why?
|
Antiviral Agents | 7 | 2022 | 3060 | 0.380 |
Why?
|
Virus Replication | 8 | 2023 | 2435 | 0.360 |
Why?
|
CD8-Positive T-Lymphocytes | 15 | 2024 | 4580 | 0.360 |
Why?
|
Camelids, New World | 3 | 2014 | 20 | 0.340 |
Why?
|
Evolution, Molecular | 5 | 2015 | 1886 | 0.330 |
Why?
|
Inhibitory Concentration 50 | 9 | 2019 | 465 | 0.330 |
Why?
|
H-2 Antigens | 2 | 2000 | 357 | 0.330 |
Why?
|
Vaccines, Synthetic | 9 | 2018 | 616 | 0.330 |
Why?
|
Immune Evasion | 3 | 2021 | 363 | 0.330 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 6 | 2023 | 303 | 0.320 |
Why?
|
Milk, Human | 2 | 2011 | 486 | 0.320 |
Why?
|
Complementarity Determining Regions | 7 | 2024 | 149 | 0.320 |
Why?
|
Cryoelectron Microscopy | 9 | 2024 | 650 | 0.310 |
Why?
|
Virion | 4 | 2018 | 422 | 0.310 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 21 | 2016 | 3810 | 0.310 |
Why?
|
Immunotherapy | 8 | 2024 | 4652 | 0.310 |
Why?
|
Peptide Fragments | 11 | 2021 | 5112 | 0.300 |
Why?
|
Crystallography, X-Ray | 14 | 2021 | 1990 | 0.300 |
Why?
|
Vaccines | 4 | 2023 | 844 | 0.300 |
Why?
|
Protein Multimerization | 10 | 2021 | 983 | 0.300 |
Why?
|
Anti-HIV Agents | 9 | 2022 | 4527 | 0.300 |
Why?
|
Immunity, Humoral | 8 | 2021 | 606 | 0.300 |
Why?
|
Adjuvants, Immunologic | 5 | 2020 | 1036 | 0.290 |
Why?
|
Molecular Sequence Data | 29 | 2015 | 17635 | 0.290 |
Why?
|
Lymphocyte Activation | 10 | 2020 | 5485 | 0.290 |
Why?
|
Epitope Mapping | 7 | 2020 | 298 | 0.280 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2015 | 1349 | 0.270 |
Why?
|
Guinea Pigs | 10 | 2020 | 1310 | 0.270 |
Why?
|
RNA, Viral | 10 | 2020 | 2846 | 0.270 |
Why?
|
Protein Binding | 19 | 2023 | 9353 | 0.260 |
Why?
|
Virus Latency | 3 | 2022 | 363 | 0.260 |
Why?
|
Mutation | 29 | 2024 | 30053 | 0.260 |
Why?
|
Injections, Intramuscular | 8 | 2020 | 554 | 0.250 |
Why?
|
Glycosylation | 9 | 2021 | 1097 | 0.250 |
Why?
|
Immunoglobulin Variable Region | 6 | 2021 | 419 | 0.250 |
Why?
|
Primates | 4 | 2021 | 523 | 0.240 |
Why?
|
Recombinant Proteins | 16 | 2021 | 6534 | 0.240 |
Why?
|
Listeriosis | 3 | 2000 | 149 | 0.240 |
Why?
|
Food Contamination | 1 | 2006 | 191 | 0.240 |
Why?
|
Rabbits | 13 | 2023 | 4772 | 0.240 |
Why?
|
Leukocytes, Mononuclear | 9 | 2019 | 1844 | 0.240 |
Why?
|
Cell Line | 22 | 2021 | 15601 | 0.240 |
Why?
|
Epitopes, T-Lymphocyte | 9 | 2018 | 828 | 0.230 |
Why?
|
Mice | 43 | 2024 | 81539 | 0.220 |
Why?
|
Monkeypox virus | 1 | 2023 | 42 | 0.220 |
Why?
|
Immunoglobulin Heavy Chains | 6 | 2019 | 647 | 0.220 |
Why?
|
Phylogeny | 12 | 2022 | 2811 | 0.220 |
Why?
|
Double-Blind Method | 16 | 2024 | 12341 | 0.220 |
Why?
|
Immunoglobulin Fc Fragments | 3 | 2021 | 280 | 0.210 |
Why?
|
Surface Plasmon Resonance | 8 | 2020 | 269 | 0.210 |
Why?
|
Listeria monocytogenes | 3 | 2000 | 249 | 0.210 |
Why?
|
Animals, Wild | 1 | 2023 | 78 | 0.210 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.210 |
Why?
|
Epidemics | 2 | 2021 | 512 | 0.200 |
Why?
|
Convalescence | 1 | 2022 | 105 | 0.200 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2022 | 72 | 0.200 |
Why?
|
Genotype | 3 | 2015 | 12990 | 0.200 |
Why?
|
Vaccinia | 2 | 2013 | 71 | 0.200 |
Why?
|
Mucous Membrane | 3 | 2018 | 659 | 0.200 |
Why?
|
Disease Reservoirs | 2 | 2019 | 121 | 0.200 |
Why?
|
Immunity, Mucosal | 4 | 2014 | 483 | 0.200 |
Why?
|
Macaca | 6 | 2022 | 410 | 0.190 |
Why?
|
Gene Products, gag | 5 | 2020 | 312 | 0.190 |
Why?
|
Interleukin-12 | 1 | 2004 | 584 | 0.190 |
Why?
|
Receptors, Virus | 3 | 2021 | 640 | 0.180 |
Why?
|
Single-Chain Antibodies | 2 | 2019 | 111 | 0.180 |
Why?
|
Recombination, Genetic | 3 | 2018 | 1519 | 0.180 |
Why?
|
Female | 75 | 2024 | 392705 | 0.180 |
Why?
|
Commerce | 1 | 2006 | 607 | 0.180 |
Why?
|
Hinge Exons | 1 | 2020 | 2 | 0.180 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2021 | 545 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.180 |
Why?
|
Vaccines, Attenuated | 5 | 2016 | 315 | 0.170 |
Why?
|
Male | 61 | 2024 | 360846 | 0.170 |
Why?
|
Clone Cells | 4 | 2019 | 1659 | 0.170 |
Why?
|
Protein Structure, Tertiary | 10 | 2018 | 3792 | 0.170 |
Why?
|
Immunoglobulin Light Chains | 3 | 2016 | 285 | 0.170 |
Why?
|
Receptors, HIV | 4 | 2013 | 159 | 0.170 |
Why?
|
Dose-Response Relationship, Immunologic | 4 | 2018 | 364 | 0.170 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2021 | 326 | 0.170 |
Why?
|
Drug Users | 1 | 2021 | 134 | 0.170 |
Why?
|
BCG Vaccine | 1 | 2022 | 369 | 0.170 |
Why?
|
T-Lymphocytes | 13 | 2019 | 10194 | 0.170 |
Why?
|
Vaccines, Inactivated | 1 | 2020 | 179 | 0.170 |
Why?
|
Animals, Newborn | 2 | 2024 | 2677 | 0.170 |
Why?
|
Mannose | 2 | 2016 | 121 | 0.160 |
Why?
|
DNA Primers | 3 | 2016 | 2820 | 0.160 |
Why?
|
Proviruses | 4 | 2023 | 313 | 0.160 |
Why?
|
Disease Models, Animal | 16 | 2024 | 18255 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2017 | 1435 | 0.160 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2013 | 2199 | 0.160 |
Why?
|
Mutant Proteins | 4 | 2015 | 491 | 0.160 |
Why?
|
Antigen-Antibody Complex | 3 | 2021 | 510 | 0.160 |
Why?
|
Receptors, Fc | 3 | 2017 | 535 | 0.160 |
Why?
|
Luminescent Measurements | 1 | 2020 | 342 | 0.150 |
Why?
|
Drug Carriers | 3 | 2018 | 706 | 0.150 |
Why?
|
Biological Clocks | 1 | 2020 | 318 | 0.150 |
Why?
|
Sequence Alignment | 7 | 2020 | 2180 | 0.150 |
Why?
|
T-Lymphocyte Subsets | 5 | 2018 | 1802 | 0.150 |
Why?
|
Vaccines, Subunit | 4 | 2024 | 161 | 0.140 |
Why?
|
Half-Life | 4 | 2022 | 651 | 0.140 |
Why?
|
Antigens | 3 | 2017 | 1443 | 0.140 |
Why?
|
Immunodominant Epitopes | 3 | 2019 | 239 | 0.140 |
Why?
|
Macaca fascicularis | 4 | 2020 | 903 | 0.140 |
Why?
|
Immunocompromised Host | 2 | 2020 | 858 | 0.140 |
Why?
|
Gene Knock-In Techniques | 2 | 2016 | 421 | 0.140 |
Why?
|
HLA-B27 Antigen | 1 | 2017 | 63 | 0.140 |
Why?
|
Recombinant Fusion Proteins | 2 | 2024 | 3733 | 0.140 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2017 | 45 | 0.140 |
Why?
|
Injections, Intradermal | 3 | 2014 | 116 | 0.140 |
Why?
|
Toll-Like Receptor 7 | 1 | 2018 | 177 | 0.140 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 662 | 0.140 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 529 | 0.140 |
Why?
|
Antigen-Antibody Reactions | 2 | 2021 | 340 | 0.130 |
Why?
|
Disease Outbreaks | 1 | 2006 | 1749 | 0.130 |
Why?
|
Receptors, CCR5 | 3 | 2015 | 486 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2020 | 602 | 0.130 |
Why?
|
Young Adult | 22 | 2024 | 59260 | 0.130 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2016 | 177 | 0.130 |
Why?
|
HLA-B Antigens | 1 | 2017 | 317 | 0.130 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2016 | 99 | 0.120 |
Why?
|
Protein Stability | 4 | 2019 | 578 | 0.120 |
Why?
|
Transduction, Genetic | 1 | 2018 | 903 | 0.120 |
Why?
|
Models, Animal | 1 | 2021 | 2112 | 0.120 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 4 | 2020 | 398 | 0.120 |
Why?
|
Adult | 34 | 2024 | 221210 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 8 | 2017 | 2571 | 0.120 |
Why?
|
Gene Expression | 4 | 2019 | 7581 | 0.120 |
Why?
|
Polyvinyls | 2 | 2012 | 154 | 0.120 |
Why?
|
Lymphocyte Depletion | 1 | 2016 | 602 | 0.110 |
Why?
|
Phagocytosis | 1 | 2020 | 1528 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1347 | 0.110 |
Why?
|
Cochlea | 1 | 2020 | 845 | 0.110 |
Why?
|
Skin Absorption | 1 | 2013 | 94 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1352 | 0.110 |
Why?
|
Antibodies | 3 | 2023 | 2418 | 0.110 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2024 | 3080 | 0.110 |
Why?
|
CD4 Immunoadhesins | 1 | 2013 | 12 | 0.110 |
Why?
|
Fowlpox virus | 2 | 2012 | 21 | 0.110 |
Why?
|
Serum | 1 | 2014 | 209 | 0.110 |
Why?
|
Virulence | 4 | 2017 | 1303 | 0.110 |
Why?
|
Orthopoxvirus | 1 | 2012 | 11 | 0.110 |
Why?
|
Microinjections | 1 | 2013 | 321 | 0.110 |
Why?
|
Drug Design | 3 | 2013 | 1048 | 0.100 |
Why?
|
Hearing Loss | 1 | 2020 | 783 | 0.100 |
Why?
|
Dependovirus | 2 | 2015 | 718 | 0.100 |
Why?
|
Antithrombin III | 1 | 2012 | 128 | 0.100 |
Why?
|
Epithelium | 1 | 2017 | 1603 | 0.100 |
Why?
|
Squalene | 1 | 2012 | 35 | 0.100 |
Why?
|
Gene Products, pol | 3 | 2020 | 43 | 0.100 |
Why?
|
Polysorbates | 1 | 2012 | 44 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2928 | 0.100 |
Why?
|
Structure-Activity Relationship | 4 | 2022 | 3076 | 0.100 |
Why?
|
DNA, Viral | 4 | 2013 | 2202 | 0.100 |
Why?
|
Immunoglobulins | 1 | 2015 | 852 | 0.100 |
Why?
|
Placenta | 1 | 2020 | 1709 | 0.090 |
Why?
|
Poxviridae | 3 | 2019 | 37 | 0.090 |
Why?
|
Amino Acid Substitution | 4 | 2021 | 1739 | 0.090 |
Why?
|
Cancer Vaccines | 2 | 2017 | 1051 | 0.090 |
Why?
|
Middle Aged | 27 | 2024 | 220921 | 0.090 |
Why?
|
Adenoviridae Infections | 1 | 2011 | 93 | 0.090 |
Why?
|
Capsid Proteins | 1 | 2014 | 468 | 0.090 |
Why?
|
High-Throughput Screening Assays | 2 | 2013 | 934 | 0.090 |
Why?
|
Needles | 1 | 2013 | 451 | 0.090 |
Why?
|
Kinetics | 5 | 2024 | 6374 | 0.090 |
Why?
|
Administration, Intravaginal | 3 | 2020 | 150 | 0.090 |
Why?
|
Plasmids | 5 | 2011 | 2269 | 0.090 |
Why?
|
Plasma | 2 | 2011 | 586 | 0.090 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 962 | 0.090 |
Why?
|
Adenoviruses, Simian | 1 | 2009 | 15 | 0.080 |
Why?
|
Placebos | 3 | 2021 | 1667 | 0.080 |
Why?
|
Intestinal Mucosa | 3 | 2017 | 3032 | 0.080 |
Why?
|
Virus Shedding | 1 | 2010 | 111 | 0.080 |
Why?
|
Mice, Inbred BALB C | 7 | 2018 | 6214 | 0.080 |
Why?
|
Computational Biology | 4 | 2018 | 3517 | 0.080 |
Why?
|
Cricetulus | 3 | 2020 | 814 | 0.080 |
Why?
|
Protein Structure, Quaternary | 3 | 2021 | 429 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 1993 | 0.080 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 3 | 2016 | 206 | 0.080 |
Why?
|
Time Factors | 11 | 2020 | 39969 | 0.080 |
Why?
|
Defective Viruses | 1 | 2009 | 89 | 0.080 |
Why?
|
Mammary Glands, Animal | 1 | 2010 | 273 | 0.080 |
Why?
|
HeLa Cells | 4 | 2020 | 3094 | 0.080 |
Why?
|
Cells, Cultured | 8 | 2023 | 18966 | 0.080 |
Why?
|
Immunization Schedule | 2 | 2020 | 227 | 0.080 |
Why?
|
CHO Cells | 3 | 2020 | 1387 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2151 | 0.080 |
Why?
|
Cloning, Molecular | 4 | 2019 | 4174 | 0.080 |
Why?
|
Germinal Center | 2 | 2024 | 380 | 0.080 |
Why?
|
Lactation | 1 | 2010 | 397 | 0.080 |
Why?
|
Smallpox | 1 | 2008 | 43 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2000 | 1351 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2020 | 3769 | 0.070 |
Why?
|
Cholera Toxin | 1 | 2010 | 559 | 0.070 |
Why?
|
Protein Subunits | 2 | 2021 | 943 | 0.070 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1827 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2021 | 1897 | 0.070 |
Why?
|
Killer Cells, Natural | 2 | 2011 | 2201 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2020 | 1334 | 0.070 |
Why?
|
Conserved Sequence | 3 | 2018 | 1163 | 0.070 |
Why?
|
Escherichia coli | 1 | 2019 | 4217 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2018 | 1693 | 0.070 |
Why?
|
Amino Acids | 2 | 2024 | 1718 | 0.070 |
Why?
|
Protein Array Analysis | 1 | 2009 | 400 | 0.070 |
Why?
|
Transcytosis | 2 | 2017 | 45 | 0.070 |
Why?
|
Classical Swine Fever | 1 | 2006 | 1 | 0.070 |
Why?
|
Swine Vesicular Disease | 1 | 2006 | 1 | 0.070 |
Why?
|
Foot-and-Mouth Disease | 1 | 2006 | 7 | 0.070 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9542 | 0.070 |
Why?
|
African Swine Fever | 1 | 2006 | 7 | 0.070 |
Why?
|
Mice, Knockout | 6 | 2018 | 14417 | 0.070 |
Why?
|
Membrane Glycoproteins | 5 | 2012 | 3701 | 0.070 |
Why?
|
Injections | 2 | 2020 | 831 | 0.070 |
Why?
|
Swine Diseases | 1 | 2006 | 61 | 0.070 |
Why?
|
Drug Resistance, Viral | 3 | 2018 | 862 | 0.060 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 2004 | 321 | 0.060 |
Why?
|
Dimerization | 2 | 2021 | 891 | 0.060 |
Why?
|
Hepacivirus | 1 | 2012 | 1336 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2024 | 6312 | 0.060 |
Why?
|
Lipid Bilayers | 2 | 2018 | 383 | 0.060 |
Why?
|
Immunoconjugates | 1 | 2013 | 953 | 0.060 |
Why?
|
Polymerase Chain Reaction | 3 | 2017 | 6075 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2014 | 2748 | 0.060 |
Why?
|
Adoptive Transfer | 2 | 2019 | 819 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2016 | 3677 | 0.060 |
Why?
|
Adolescent | 12 | 2024 | 88326 | 0.060 |
Why?
|
Risk Assessment | 1 | 2006 | 23996 | 0.060 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2015 | 123 | 0.060 |
Why?
|
Spleen | 4 | 2015 | 2295 | 0.060 |
Why?
|
Amino Acid Motifs | 2 | 2019 | 931 | 0.060 |
Why?
|
Flow Cytometry | 5 | 2020 | 5870 | 0.060 |
Why?
|
Proteolipids | 2 | 2014 | 113 | 0.060 |
Why?
|
HIV Fusion Inhibitors | 2 | 2014 | 82 | 0.060 |
Why?
|
Vagina | 3 | 2020 | 838 | 0.050 |
Why?
|
Molecular Dynamics Simulation | 2 | 2018 | 437 | 0.050 |
Why?
|
Meat | 1 | 2006 | 584 | 0.050 |
Why?
|
Consensus Sequence | 2 | 2015 | 365 | 0.050 |
Why?
|
DNA | 1 | 2016 | 7213 | 0.050 |
Why?
|
Protein Structure, Secondary | 2 | 2019 | 1229 | 0.050 |
Why?
|
Antigens, Bacterial | 2 | 2016 | 1154 | 0.050 |
Why?
|
Chromatography, Gel | 2 | 2013 | 646 | 0.050 |
Why?
|
Peptide Library | 2 | 2014 | 347 | 0.050 |
Why?
|
Cytokines | 6 | 2017 | 7396 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2014 | 7593 | 0.050 |
Why?
|
Interferon-gamma | 4 | 2016 | 3162 | 0.050 |
Why?
|
Antibodies, Heterophile | 1 | 2021 | 128 | 0.050 |
Why?
|
Base Sequence | 4 | 2017 | 12441 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8656 | 0.050 |
Why?
|
Acrylic Resins | 2 | 2012 | 135 | 0.050 |
Why?
|
Cell Separation | 2 | 2017 | 1720 | 0.050 |
Why?
|
Cross-Linking Reagents | 2 | 2015 | 687 | 0.050 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 2 | 2011 | 57 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2019 | 2330 | 0.040 |
Why?
|
HLA-D Antigens | 1 | 2000 | 129 | 0.040 |
Why?
|
Dequalinium | 1 | 2020 | 7 | 0.040 |
Why?
|
Molecular Mimicry | 2 | 2011 | 213 | 0.040 |
Why?
|
Liposomes | 1 | 2024 | 783 | 0.040 |
Why?
|
HIV Protease | 2 | 2010 | 97 | 0.040 |
Why?
|
Vesiculovirus | 1 | 2020 | 55 | 0.040 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1023 | 0.040 |
Why?
|
Fluorescence Polarization | 1 | 2020 | 140 | 0.040 |
Why?
|
Cell Fusion | 1 | 2020 | 294 | 0.040 |
Why?
|
Haplorhini | 2 | 2011 | 525 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2020 | 240 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 624 | 0.040 |
Why?
|
Electrochemical Techniques | 1 | 2020 | 94 | 0.040 |
Why?
|
Mice, Inbred C57BL | 6 | 2016 | 22174 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 1999 | 1841 | 0.040 |
Why?
|
Penis | 1 | 2020 | 212 | 0.040 |
Why?
|
Cohort Studies | 6 | 2020 | 41495 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2011 | 3066 | 0.040 |
Why?
|
Cross-Priming | 1 | 2019 | 76 | 0.040 |
Why?
|
Melanoma | 2 | 2017 | 5709 | 0.040 |
Why?
|
Point Mutation | 2 | 2018 | 1595 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2021 | 452 | 0.040 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 101 | 0.040 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 253 | 0.040 |
Why?
|
Organoplatinum Compounds | 1 | 2020 | 407 | 0.040 |
Why?
|
Immune Sera | 2 | 2014 | 606 | 0.040 |
Why?
|
Bioreactors | 1 | 2019 | 247 | 0.040 |
Why?
|
Pteridines | 1 | 2018 | 47 | 0.040 |
Why?
|
Antigens, Ly | 1 | 1999 | 295 | 0.040 |
Why?
|
Remission Induction | 1 | 2024 | 2397 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2019 | 266 | 0.040 |
Why?
|
Animals, Genetically Modified | 1 | 2023 | 1561 | 0.040 |
Why?
|
Cell Membrane | 2 | 2020 | 3687 | 0.040 |
Why?
|
Peptides | 5 | 2009 | 4358 | 0.040 |
Why?
|
Drug Compounding | 1 | 2018 | 246 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10774 | 0.040 |
Why?
|
Crystallization | 1 | 2018 | 534 | 0.040 |
Why?
|
Transfection | 3 | 2013 | 5774 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 458 | 0.030 |
Why?
|
Software | 1 | 2011 | 4434 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 1999 | 778 | 0.030 |
Why?
|
Receptors, Interferon | 1 | 2017 | 116 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1601 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1091 | 0.030 |
Why?
|
Thermodynamics | 1 | 2018 | 595 | 0.030 |
Why?
|
Virus Activation | 1 | 2018 | 322 | 0.030 |
Why?
|
Antigen Presentation | 2 | 1999 | 1251 | 0.030 |
Why?
|
Liver | 4 | 2011 | 7528 | 0.030 |
Why?
|
Antigens, CD | 2 | 1999 | 4001 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1003 | 0.030 |
Why?
|
Africa, Eastern | 1 | 2016 | 76 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 5790 | 0.030 |
Why?
|
Swine | 1 | 2006 | 5915 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 1999 | 585 | 0.030 |
Why?
|
Sequence Analysis, DNA | 3 | 2013 | 4740 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1835 | 0.030 |
Why?
|
Mannosidases | 1 | 2015 | 21 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1997 | 412 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1526 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1869 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1880 | 0.030 |
Why?
|
New York | 1 | 2018 | 874 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2023 | 4937 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 518 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2023 | 1334 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2013 | 2707 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2557 | 0.030 |
Why?
|
Neutron Diffraction | 1 | 2014 | 10 | 0.030 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1459 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2018 | 64685 | 0.030 |
Why?
|
Carrier State | 1 | 2018 | 523 | 0.030 |
Why?
|
Glycoproteins | 1 | 2022 | 2203 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2013 | 5672 | 0.030 |
Why?
|
Proteins | 2 | 1999 | 6032 | 0.030 |
Why?
|
Antigens, Surface | 2 | 1999 | 1606 | 0.030 |
Why?
|
Scattering, Small Angle | 1 | 2014 | 63 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 733 | 0.030 |
Why?
|
HIV-2 | 1 | 2015 | 156 | 0.030 |
Why?
|
Systems Biology | 1 | 2018 | 481 | 0.030 |
Why?
|
Hybridomas | 1 | 2015 | 442 | 0.030 |
Why?
|
Autoantigens | 1 | 2018 | 891 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20100 | 0.030 |
Why?
|
Human Immunodeficiency Virus Proteins | 1 | 2013 | 59 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2217 | 0.030 |
Why?
|
Alleles | 3 | 2011 | 6864 | 0.030 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2013 | 162 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 221 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2017 | 2561 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2014 | 544 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 509 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 416 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 3 | 2009 | 799 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2004 | 2747 | 0.030 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1994 | 317 | 0.030 |
Why?
|
Diketopiperazines | 1 | 2013 | 24 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2013 | 102 | 0.030 |
Why?
|
Viral Tropism | 1 | 2013 | 102 | 0.030 |
Why?
|
Trifluoroethanol | 1 | 1992 | 3 | 0.030 |
Why?
|
Cameroon | 1 | 2013 | 76 | 0.030 |
Why?
|
Chick Embryo | 1 | 2015 | 982 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2021 | 0.030 |
Why?
|
Interferon Type I | 1 | 2017 | 562 | 0.030 |
Why?
|
Spiro Compounds | 1 | 2013 | 68 | 0.030 |
Why?
|
Limit of Detection | 1 | 2013 | 273 | 0.030 |
Why?
|
Probability | 1 | 2018 | 2477 | 0.030 |
Why?
|
Electroporation | 1 | 2014 | 255 | 0.030 |
Why?
|
Arginine | 1 | 2016 | 934 | 0.030 |
Why?
|
Drug Combinations | 1 | 2018 | 2048 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2014 | 439 | 0.030 |
Why?
|
Genetic Variation | 3 | 2014 | 6567 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2231 | 0.030 |
Why?
|
Ultracentrifugation | 1 | 2012 | 183 | 0.030 |
Why?
|
Geography | 1 | 2014 | 656 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2016 | 2264 | 0.020 |
Why?
|
Freund's Adjuvant | 1 | 2012 | 149 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1994 | 347 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14608 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1999 | 2112 | 0.020 |
Why?
|
Autophagy | 1 | 1999 | 1327 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2448 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2014 | 481 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2013 | 713 | 0.020 |
Why?
|
Benzoates | 1 | 2013 | 212 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9420 | 0.020 |
Why?
|
Receptors, IgG | 1 | 2014 | 559 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 847 | 0.020 |
Why?
|
Genes, Immunoglobulin Light Chain | 1 | 2010 | 2 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 832 | 0.020 |
Why?
|
Protein Folding | 1 | 2014 | 870 | 0.020 |
Why?
|
Cardiolipins | 1 | 2010 | 81 | 0.020 |
Why?
|
Cytoplasm | 1 | 2015 | 1510 | 0.020 |
Why?
|
Molecular Typing | 1 | 2011 | 116 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 2 | 1999 | 2688 | 0.020 |
Why?
|
South Africa | 1 | 2016 | 1843 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 2010 | 455 | 0.020 |
Why?
|
London | 1 | 2010 | 234 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22176 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2011 | 309 | 0.020 |
Why?
|
Immune Tolerance | 1 | 1999 | 2302 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1999 | 2827 | 0.020 |
Why?
|
Interleukin-4 | 1 | 1994 | 1149 | 0.020 |
Why?
|
Rectum | 1 | 2014 | 892 | 0.020 |
Why?
|
HIV Reverse Transcriptase | 1 | 2010 | 212 | 0.020 |
Why?
|
Th1 Cells | 1 | 1994 | 1036 | 0.020 |
Why?
|
Databases as Topic | 1 | 2011 | 473 | 0.020 |
Why?
|
Ligands | 2 | 2012 | 3272 | 0.020 |
Why?
|
Th2 Cells | 1 | 1994 | 1060 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2009 | 223 | 0.020 |
Why?
|
Viral Structural Proteins | 1 | 2009 | 95 | 0.020 |
Why?
|
Ectromelia virus | 1 | 2008 | 5 | 0.020 |
Why?
|
Genome, Viral | 1 | 2012 | 667 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2010 | 681 | 0.020 |
Why?
|
Biotinylation | 1 | 2008 | 184 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9469 | 0.020 |
Why?
|
United States | 3 | 2024 | 72340 | 0.020 |
Why?
|
Aged | 5 | 2018 | 169310 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4853 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54423 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2009 | 695 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15266 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14665 | 0.020 |
Why?
|
Colon | 1 | 2014 | 1792 | 0.020 |
Why?
|
India | 1 | 2013 | 2348 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 1741 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2007 | 1058 | 0.020 |
Why?
|
Logistic Models | 2 | 2011 | 13255 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1638 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.020 |
Why?
|
Chemoprevention | 1 | 2008 | 326 | 0.020 |
Why?
|
Adenovirus E1 Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
Adenovirus E3 Proteins | 1 | 2005 | 7 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1994 | 4352 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2011 | 819 | 0.020 |
Why?
|
Equipment Design | 1 | 2013 | 3511 | 0.020 |
Why?
|
Immunoglobulin Class Switching | 1 | 2007 | 289 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5767 | 0.020 |
Why?
|
Chemokine CCL3 | 1 | 2004 | 84 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8527 | 0.020 |
Why?
|
Fusion Proteins, gag-pol | 1 | 2004 | 7 | 0.020 |
Why?
|
Chemokine CCL4 | 1 | 2004 | 126 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3639 | 0.010 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2004 | 121 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2011 | 2358 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2010 | 1078 | 0.010 |
Why?
|
Cell Division | 2 | 1994 | 4465 | 0.010 |
Why?
|
Granzymes | 1 | 2006 | 277 | 0.010 |
Why?
|
Gene Products, nef | 1 | 2004 | 100 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2018 | 11530 | 0.010 |
Why?
|
Algorithms | 2 | 2018 | 14033 | 0.010 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 148 | 0.010 |
Why?
|
Immune System | 1 | 2009 | 796 | 0.010 |
Why?
|
Cricetinae | 1 | 2007 | 2423 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10451 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2013 | 2220 | 0.010 |
Why?
|
Information Dissemination | 1 | 2011 | 1126 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1987 | 2496 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15843 | 0.010 |
Why?
|
Interleukin-2 | 2 | 2003 | 1889 | 0.010 |
Why?
|
Piperazines | 1 | 2013 | 2523 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4111 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1999 | 6131 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11904 | 0.010 |
Why?
|
Chemotaxis | 1 | 2004 | 598 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 2414 | 0.010 |
Why?
|
Pregnancy | 2 | 2020 | 29890 | 0.010 |
Why?
|
Viral Proteins | 1 | 2008 | 1804 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26202 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8002 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2691 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 9001 | 0.010 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 1999 | 30 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 1999 | 30 | 0.010 |
Why?
|
Patient Selection | 1 | 2011 | 4244 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 1999 | 84 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9280 | 0.010 |
Why?
|
Cell-Free System | 1 | 1999 | 340 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1657 | 0.010 |
Why?
|
Apoptosis | 1 | 1994 | 9490 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1999 | 418 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2665 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 4618 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10766 | 0.010 |
Why?
|
Vacuoles | 1 | 1997 | 228 | 0.010 |
Why?
|
Vesicular Transport Proteins | 1 | 1999 | 376 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39106 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1997 | 325 | 0.010 |
Why?
|
DNA, Fungal | 1 | 1997 | 275 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7391 | 0.010 |
Why?
|
Genes, Fungal | 1 | 1997 | 439 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2578 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1999 | 2016 | 0.010 |
Why?
|
Cell Size | 1 | 1997 | 624 | 0.010 |
Why?
|
Fungal Proteins | 1 | 1999 | 910 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2004 | 7859 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1999 | 1206 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 1999 | 1136 | 0.010 |
Why?
|
Thymus Gland | 1 | 1999 | 1243 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 1994 | 216 | 0.010 |
Why?
|
Mitogens | 1 | 1994 | 230 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16990 | 0.010 |
Why?
|
Chronic Disease | 1 | 2008 | 9319 | 0.010 |
Why?
|
Trifluoroacetic Acid | 1 | 1992 | 5 | 0.010 |
Why?
|
Mice, Nude | 1 | 1999 | 3614 | 0.010 |
Why?
|
Lethal Dose 50 | 1 | 1992 | 72 | 0.010 |
Why?
|
Acetaldehyde | 1 | 1992 | 39 | 0.010 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 1992 | 35 | 0.010 |
Why?
|
Signal Transduction | 2 | 2012 | 23447 | 0.010 |
Why?
|
Biotransformation | 1 | 1992 | 166 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1992 | 173 | 0.010 |
Why?
|
CD40 Ligand | 1 | 1994 | 522 | 0.010 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1992 | 110 | 0.010 |
Why?
|
Mitochondria, Liver | 1 | 1992 | 190 | 0.010 |
Why?
|
Phenobarbital | 1 | 1992 | 191 | 0.010 |
Why?
|
Fetus | 1 | 1999 | 1863 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1992 | 532 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1994 | 898 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4615 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11076 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1992 | 412 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1248 | 0.010 |
Why?
|
Cytosol | 1 | 1992 | 888 | 0.010 |
Why?
|
Interleukins | 1 | 1994 | 782 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13510 | 0.010 |
Why?
|
Infant | 1 | 2011 | 36193 | 0.000 |
Why?
|
Rats, Wistar | 1 | 1992 | 1848 | 0.000 |
Why?
|
NAD | 1 | 1992 | 614 | 0.000 |
Why?
|
Leukemia L1210 | 1 | 1987 | 44 | 0.000 |
Why?
|
Leukemia, Experimental | 1 | 1987 | 225 | 0.000 |
Why?
|
Ethanol | 1 | 1992 | 1324 | 0.000 |
Why?
|
Brain | 1 | 2013 | 27121 | 0.000 |
Why?
|
Up-Regulation | 1 | 1994 | 4125 | 0.000 |
Why?
|
Liver Diseases | 1 | 1992 | 1297 | 0.000 |
Why?
|
Cell Survival | 1 | 1994 | 5791 | 0.000 |
Why?
|
Child | 1 | 2011 | 80158 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1987 | 1745 | 0.000 |
Why?
|
DNA Replication | 1 | 1987 | 1418 | 0.000 |
Why?
|
Aging | 1 | 1999 | 8710 | 0.000 |
Why?
|
Leukemia | 1 | 1987 | 1522 | 0.000 |
Why?
|
Cell Cycle | 1 | 1987 | 2932 | 0.000 |
Why?
|
Rats | 1 | 1992 | 23741 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1999 | 21019 | 0.000 |
Why?
|